Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Eric Warga"'
Publikováno v:
Molecular Therapy: Nucleic Acids, Vol 31, Iss , Pp 43-56 (2023)
The innate immune response to cytosolic DNA is intended to protect the host from viral infections, but it can also inhibit the delivery and expression of therapeutic transgenes in gene and cell therapies. The goal of this work was to use mRNA sequenc
Externí odkaz:
https://doaj.org/article/aec02925143b4ae2ad5c9b27836c0554
The innate immune response to cytosolic DNA is intended to protect the host from viral infections, but it can also inhibit the delivery and expression of therapeutic transgenes in gene and cell therapies. The goal of this work was to use mRNA-sequenc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::764669629b67148d218bbb9762c0e451
https://doi.org/10.1101/2021.06.21.449271
https://doi.org/10.1101/2021.06.21.449271
Publikováno v:
Molecular therapy. Nucleic acids. 31
The innate immune response to cytosolic DNA is intended to protect the host from viral infections, but it can also inhibit the delivery and expression of therapeutic transgenes in gene and cell therapies. The goal of this work was to use mRNA sequenc
Publikováno v:
Biotechnology and bioengineeringREFERENCES. 118(4)
Retroviral gene delivery is widely used in T cell therapies for hematological cancers. However, viral vectors are expensive to manufacture, integrate genes in semi-random patterns, and their transduction efficiency varies between patients. In this st
Retroviral gene delivery is widely used in T cell therapies for hematological cancers. However, viral vectors are expensive to manufacture, they integrate genes in semi-random patterns, and their transduction efficiency is highly variable. In this st
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::54a5b410b2ce8391a4dadfd4f12cab52
https://doi.org/10.22541/au.160262388.84292192/v1
https://doi.org/10.22541/au.160262388.84292192/v1
Publikováno v:
Nano LIFE. 11:2130002
Nonviral gene delivery (NVGD) is an appealing alternative to viral gene delivery for clinical applications due to its lower cost and increased safety. A variety of promising nonviral vectors are under development, including cationic polymers, lipids,